Bard Associates’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.1K Hold
2,500
0.01% 186
2025
Q4
$22.4K Sell
2,500
-41,900
-94% -$401K 0.01% 178
2025
Q3
$460K Sell
44,400
-1,200
-3% -$9.96K 0.12% 119
2025
Q2
$285K Sell
45,600
-16,000
-26% -$88.4K 0.09% 141
2025
Q1
$331K Buy
61,600
+5,000
+9% +$36.6K 0.12% 135
2024
Q4
$478K Hold
56,600
0.16% 121
2024
Q3
$379K Sell
56,600
-500
-0.9% -$3.24K 0.13% 138
2024
Q2
$390K Sell
57,100
-25
-0% -$184 0.15% 129
2024
Q1
$490K Buy
57,125
+4,100
+8% +$38.5K 0.18% 121
2023
Q4
$559K Buy
53,025
+250
+0.5% +$2.46K 0.21% 116
2023
Q3
$509K Buy
52,775
+4,115
+8% +$42.1K 0.21% 118
2023
Q2
$469K Sell
48,660
-50
-0.1% -$453 0.18% 119
2023
Q1
$378K Buy
48,710
+2,300
+5% +$21.2K 0.16% 133
2022
Q4
$403K Buy
+46,410
New +$378K 0.17% 124

Other funds holding INFU

Bard Associates's INFU Position: Q1 2026 in Review

Bard Associates held its InfuSystem Holdings (INFU) position steady in Q1 2026 at 2,500 shares worth $23.1K. The position accounts for 0.01% of the portfolio, ranked #186.

Bard Associates first reported a position in INFU in Q4 2022 and has held it in 14 quarters since. The position peaked at $559K in Q4 2023. 96 funds tracked by Wall St. Rank hold INFU as of Q1 2026.

  • Bard Associates held 2,500 shares of InfuSystem Holdings worth $23.1K as of Q1 2026.
  • Bard Associates left its InfuSystem Holdings share count unchanged in Q1 2026.
  • InfuSystem Holdings made up 0.01% of Bard Associates's portfolio in Q1 2026, its #186 holding.
  • Bard Associates first reported a position in InfuSystem Holdings in Q4 2022 and has held it in 14 quarters since.
  • Bard Associates's InfuSystem Holdings position peaked at $559K in Q4 2023.
  • 96 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2026.

Based on Bard Associates's 13F filing for Q1 2026, filed 8 May 2026.